Purpose of Review <p>This review aims to explore the multifaceted landscape of breast cancer, focusing on the crucial role of genetic and genomic studies in understanding its heterogeneity and guiding personalized treatment strategies. It seeks to address the genetic underpinnings of breast cancer and the potential for developing targeted therapies.</p> Recent Findings <p>Recent advancements in genome-wide analysis and next-generation sequencing technologies have significantly advanced our understanding of the genetic complexities of breast cancer. Key discoveries include gene copy number alterations, mutational signatures, and intricate patterns of intra-tumoral heterogeneity. Specific genetic aberrations, such as the “kataegis” phenomenon and mutations in the integrin signaling pathway, have been identified, providing new avenues for therapeutic intervention. These findings highlight the diversity of breast cancer subtypes, including triple-negative breast cancer (TNBC), and underscore the importance of personalized medicine.</p> Summary <p>The review concludes that dissecting the genomic landscape of breast cancer reveals significant genetic diversity and potential targets for therapy. Identifying specific genetic alterations holds promise for developing targeted therapies, emphasizing the necessity of personalized medicine in breast cancer care. Despite challenges in integrating these genetic insights into clinical practice, the potential for more effective and tailored treatment approaches is substantial. Future research should focus on overcoming these challenges to fully realize the benefits of personalized medicine for breast cancer patients.</p>